Press release
Neurofibromatosis Treatment Market Research Report by Regional Analysis, Key Players, Share, Size and forecast 2023
The tumors are noncancerous (benign) in most of the cases, but in some cases these tumors become cancerous (malignant) tumors. People suffering with neurofibromatosis often experience only mild symptom and effects may range from hearing loss, learning impairment, and heart and blood vessel (cardiovascular) complications to severe disability due to nerve compression by tumors, loss of vision and severe pain. There is no specific treatment for neurofibromatosis, but treatment aims to maximize healthy growth and development and to manage complications as soon as they arise. When neurofibromatosis causes large tumors or tumors that press on a nerve, surgery may help ease symptoms. Other therapies such as stereotactic radiosurgery, medications to control pain or physical therapy are proved to be beneficial for the affected people.
There are three types of neurofibromatosis, known as neurofibromatosis type 1 (NF1), the most common one, and neurofibromatosis type 2 (NF2). One more type of neurofibromatosis which has been identified recently is known as Schwannomatosis, is a rare type and little is known about it. The factors that would drive the neurofibromatosis treatment market includes the drugs which are in the clinical trials and are anticipated to be a break through treatment for neurofibromatosis cases.
Browse full report on Neurofibromatosis Treatment Market -
http://www.transparencymarketresearch.com/neurofibromatosis-treatment-market.html
The neurofibromatosis treatment market can be segmented into drug therapy, surgery, radiation therapy and chemotherapy. Surgery is the most preferred option for the removal of the tumors. Other treatments like radiation therapy and chemotherapy are also recommended in the neurofibromatosis treatments market. In case of NF2 tumors, MRI can felicitate the early treatment of the tumors by revealing the size of the tumors. Surgery to remove tumors completely is one option but may result in hearing loss. Surgery also can correct cataracts and retinal abnormalities. There is no currently accepted medical treatment or drug for schwanomatosis, but surgical management is often effective. Pain usually subsides when tumors are removed completely.
There are currently no drugs in the market for neurofibromatosis treatment, however ever certain drugs in the phase III of the clinical trials include Lamotrigine (Erasmus Medical Center), and Tamsulosin HCL (GL Pharm Tech Corporation). The drugs in the phase II of the clinical trials include Cabozantinib (University of Alabama at Birmingham), RAD001 (Assistance Publique - Hôpitaux de Paris), Gleevec (Indiana University), Everolimus (Texas Neurofibromatosis Foundation) and others.
Geographically, Neurofibromatosis is an orphan disease, and the prevalence rate of neurofibromatosis is low. According to oxford journals the prevalence rate defers from region to region. The prevalence in the U.S. is 1 in 3,000, in Eastern Europe is 1 in 15,000, in Oceania is 1 in 10,000 and in Western Europe and Middle East is 1 in 10,000.
The organization and institutes participating in the neurofibromatosis treatment market include Erasmus Medical Center, GL Pharm Tech Corporation, University of Alabama at Birmingham, Assistance Publique - Hôpitaux de Paris, Indiana University, Texas Neurofibromatosis Foundation and others. The institutes and organization are involved in discovering of novel drug therapy for the treatment of Neurofibromatosis.
Request for brochure of this report -
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7156
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurofibromatosis Treatment Market Research Report by Regional Analysis, Key Players, Share, Size and forecast 2023 here
News-ID: 480388 • Views: …
More Releases from Transparency Market Research - Healthcare IT
Healthcare Information Systems Market - Increasing Government Funding for Health …
The leading players in the global healthcare information systems market are Cerner Corporation, McKesson, and All Scripts. Collectively, these players held a share of 26% in the global market in 2015, states Transparency Market Research. The diversified portfolio of these companies is expected to help them maintain a lead in the coming years. Several companies in the global healthcare information systems market are expected to focus on increasing geographical presence…
Healthcare Automation Market - Therapeutic Automation Remains Dominant Technolog …
Transparency Market Research (TMR) states that Siemens AG, General Electric Company, Swisslog Holding AG, and Koninklijke Philips N.V. are some of the leading companies in the global healthcare automation market. These players have consistently worked toward expansion of product portfolio and reinforcing business through innovation product development. In the coming years, to beat the competition, players are expected to plan for mergers and acquisitions to expand their horizons to newer…
Technology Spending on Revenue Cycle Management Market - APAC Grows Stronger in …
McKesson Corporation, Allscripts, Cerner Corporation, and Optum Health, Inc. were the leading players in the global market for technology spending on revenue cycle management in 2015. These key companies show the common strengths in having built strong distribution channels and effective long-term partnerships.
Download Sample Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17597
According to a research report released by Transparency Market Research, technology spending on revenue cycle management is expected to experience a buildup in competitive rivalries…
Smart Healthcare Products Market: Integration of IoT and Big Data with Smart Hea …
The global smart healthcare products market is fragmented due to presence of high number of players who offer differentiated products. This allows players to focus on specific product types thus increasing their market presence. For instance, in 2014, Becton Dickinson & Company and Medtronic again were among leading vendors in smart syringes, Medtronic and Olympus Corporation led the smart pills sales, and Epic Systems Corporation and Allscripts Healthcare Solutions were…
More Releases for Neurofibromatosis
Neurofibromatosis Type-2 Market Insight, Epidemiology and Market Forecast - 2027
Neurofibromatosis Type-2 Market research report is the new statistical data source added by Infinity Business Insights.
The genetic disease neurofibromatosis type 2 (NF2) is most often linked with bilateral vestibular schwannomas, also known as auditory neuromas. These benign (noncancerous) tumours develop on the balance and hearing nerves that go to the inner ear. Although benign, these tumours can cause hearing and balance issues. People with NF2 are also more likely…
Global Neurofibromatosis Treatment Drug Industry Market Research Report from 202 …
Global Info Research has published an effective statistical data titled as Neurofibromatosis Treatment Drug Market. It defines about the recent innovations, applications and end users of the market. It covers the different aspects, which are responsible for the growth of the industries. Different domains are considered on the basis of the capital of Neurofibromatosis Treatment Drug market. The analyst examines different companies on the basis of their productivity to review the current strategies. All…
Neurofibromatosis Treatment Market to Set Phenomenal Growth by 2023
Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue. These formed tumors may develop anywhere in the nervous system of the victim, which may include the brain, spinal cord and nerves. Neurofibromatosis is usually diagnosed in childhood or early adulthood. The tumors are noncancerous (benign) in most of the cases, but in some cases these tumors become cancerous…
Neurofibromatosis Type I Market to Rear Excessive Growth During 2016-2024
Neurofibromatosis is caused due to a genetic mutation, resulting in the formation of tumors in various parts of a body, along nerve tissues, brain, and spinal cord. Among the three types of this disease, neurofibromatosis type I (NF1) is the most common. Often diagnosed in early adulthood or childhood, NF1 records to affect one behind each 2,000-2,500 people worldwide. Neurofibromatosis type I is characterized by severe skin pigmentation i.e. skin…
Neurofibromatosis Treatment Market Research Report Forecast to 2023
Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue. These formed tumors may develop anywhere in the nervous system of the victim, which may include the brain, spinal cord and nerves. Neurofibromatosis is usually diagnosed in childhood or early adulthood. The tumors are noncancerous (benign) in most of the cases, but in some cases these tumors become cancerous…
Global Neurofibromatosis Treatment Market: Expected to Provide Suitable Growth b …
Neurofibromatosis is a rare nervous system disease caused due to genetic disorder. Tumors formed anywhere on the nervous system, are cancerous or non cancerous. Neurofibromatosis effects are distinct. These effects can be extremely painful in some victims, while it is hardly noticeable in others. Neurofibromatosis is divided into three types such as NF1, NF2 and schwannomatosis. NF1 is mild, common and evident at early age. NF2 known as acoustic…
